Clinical trial Recruiting at 1 site Observational Ages 50 and up

New assessment tool for evaluating memory in Alzheimer's patients

Official title: Development, Standardisation and Standardisation Project for a New Memory Assessment

Run by University Hospital, Tours · NCT06564779 · Data updated 2026-11-12

This study is testing a new memory tool for people with Alzheimer's to see if it can better understand their memory issues compared to traditional methods.

Quick facts

Study typeObservational
Ages50 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Tours
Academic / other
Locations1 site (Tours)
StatusRecruiting
StartedNovember 22, 2024
Main results expectedNovember 2028
Study endsNovember 2028
Registry record updatedApril 30, 2026
Trial IDNCT06564779 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 50 and older with an amnesic mild cognitive impairment profile.

Probably not a fit

Patients with severe sensory impairments or those unable to participate in neuropsychological assessments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate a new tool called the New Evaluation of Episodic Memory (NEM) designed to assess episodic memory in patients with Alzheimer's disease. The NEM incorporates emotional and identity aspects of memory, which are often overlooked in traditional assessments. By analyzing response profiles from patients, the study seeks to determine the tool's effectiveness in differentiating Alzheimer's disease from other memory disorders. Participants will be assessed based on specific eligibility criteria, including age and cognitive profile.

Why it matters

Potential benefit: If successful, this assessment tool could lead to more accurate diagnoses of Alzheimer's disease and improve patient care.

How similar studies have gone: Preliminary studies have shown promise for similar approaches, indicating potential for success in this novel assessment method.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 50 years
* Ability to understand judged sufficient by the assessor;
* Amnesic MCI profile (Petersen, 2003) during the 1st medical consultation prior to the assessment being prescribed.

Exclusion Criteria:

* Severe auditory and/or visual sensory impairment not compatible with neuropsychological assessment;
* Judged fit to take the test by the assessor;
* Patient under guardianship, curatorship or family guardianship;
* Opposition to data processing.

Where it's running

  • University hospital
    Tours, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.